1. Articles from Alex Lawson

    1-1 of 1
    1. Activist Investor Secures Meeting With GSK Chairman and the Backing of Corporate Raider

      Activist Investor Secures Meeting With GSK Chairman and the Backing of Corporate Raider

      An activist investor pushing for a shake-up at GlaxoSmithKline has secured a meeting with the drugs giant's chairman – and the backing of corporate raider Elliott. Sources said Bluebell Capital Partners is due to meet Sir Jonathan Symonds within weeks. Bluebell wants GSK chief executive Emma Walmsley to reapply for her job ahead of the separation of the group's biopharma and consumer businesses next year...

      Read Full Article
      Mentions: Management stake GSK
    1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics in the News

    1. (1 articles) Emma Walmsley
    2. (1 articles) Bluebell Capital
    3. (1 articles) Elliott Management
    4. (1 articles) Biopharma
    5. (1 articles) GlaxoSmithKline
    6. (1 articles) GSK
    7. (1 articles) Bluebell
    8. (1 articles) Management
    9. (1 articles) stake
    10. (1 articles) activist investor
  3. Popular Articles

  4. Picture Gallery

    Activist Investor Secures Meeting With GSK Chairman and the Backing of Corporate Raider Wetherspoon Boss Accuses Fidelity of Hypocrisy in Board Spat Jamieson Wellness Inc. Announces Appointment of New Director Elizabeth Holmes Points Fingers at Others and Says She Was a Believer SM Energy Announces The Appointment Of Anita M. Powers To The Company's Board Of Directors II-VI Appoints CEO Chuck Mattera to Chairman Role, Makes Other Board Announcements AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors ITC Holdings Corp. Makes Two New Appointments to Board of Directors Paychex Board of Directors Announce Appointments of Martin Mucci as Board Chair and CEO and John Gibson as President and Chief Operating Officer A Tech Whistle-Blower Helps Others Speak Out ProPetro Avoids Fine in Executive Perk Case; ex-CEO to Pay $195K The Poison Pill, Long Hated by Investors, Gets New Love in Japan